![LungSpecialist Profile](https://pbs.twimg.com/profile_images/1845157165100601355/qictHIJa_x96.jpg)
LungSpecialist
@LungConsultant
Followers
4K
Following
6K
Statuses
2K
Professor Neal Navani MA MSc PhD FRCP, Consultant in Thoracic Medicine @uclh, Professor @uclrespiratory, Clinical Director, Centre for Cancer Outcomes
London, England
Joined April 2012
RT @DrSarahEJackson: New paper explores changing patterns of 'dual use' of vaping and smoking in England in the context of a rapidly evolvi…
0
26
0
RT @CharlesSwanton: Our paper describing the use of an ultrasensitive circulating tumour DNA detection assay to stratify #TRACERx patients…
0
81
0
RT @OlympusMedUKIE: Register Now: Medical Expert Training in Peripheral Bronchoscopy 🫁 Enhance your knowledge and confidence with #Periphe…
0
1
0
New @BTSrespiratory @NICEComms guidelines on diagnosis and management of asthma published this week. Contains important info on carbon footprint of inhalers. #BTSWinter2024
2
40
73
Some personal news - I’m thrilled to announce my promotion to Professor of Respiratory Medicine at @uclmedsci. 🫁 I am hugely grateful to my family, friends & so many wonderful colleagues @uclh @ucl & worldwide for their support and inspiration ♥️
52
7
267
Celebrating 20 years of EBUS at #ERS2024 EBUS enables rapid, accurate and comprehensive diagnosis and staging of lung cancer and high quality #EBUS is central to #lungcancer care
2
8
39
RT @AusLucap: Agreed standards of #lungacncer care for Aus & NZ published now: This represents a critical step for…
0
8
0
RT @EricTopol: In @NEJM today, @hilaryarobbins on multicancer early detection tests and hard evidence for their benefit
0
54
0
@NLCA have started to receive data on pts who were diagnosed via the TLHC programme and we plan to include these data in the 2025 report. Currently received 225 pts in 2023 diagnosed via TLHC when it should be >1000. Please do submit this info via COSD field CR1600 option 17
1
10
24
RT @JournalCancer: A standing ovation for our Editor-in-Chief @RamalingamMD after his @ASCO Plenary presentation on findings from the phase…
0
16
0
RT @BTOGORG: Now available on-demand to members ... #BTOGNLCAWebinar: The State of the Nation 2024 Via our Members' Library; CPD available…
0
8
0
RT @FordePatrick: Big day for small cell lung cancer! Durable responses for some pts albeit the requirements for monitoring for CRS will ma…
0
8
0
A fantastic meeting in Heidelberg with interventional pulmonology colleagues from around the world. So inspiring to see such high quality research. Local delivery of therapies for #lungcancer are not too far away Thanks @lonnyyarmus @Bronchking @kimyw_snu_pulm
0
4
12
Amazing to see @uclmedsci ranked 1st for medical research in Europe and 3rd in the world 👏🏼👏🏼 @lungsforliving
2
12
50
RT @UKlungcancer: Read our blog on the important and encouraging findings from the latest @nlca_uk 'State of the Nation Report 2024' by @Dr…
0
4
0
RT @NLCA_uk: 🎥 NLCA clinical fellow @DrLaurenDixon talking to @VJOncology about the State of the Nation 2024 ⭐️ @BTOGORG @NATCAN_news https…
0
5
0
Fantastic to be part of this lung cancer team at an inspiring #BTOG24
@uclh @uclcancer @lungsforliving @CharlesSwanton @ProfSiowMingLee @DrTanyaAhmad1 @ricky_thakrar @crispinhiley
#LCSM
0
4
46
Dr Priyam Verghese @lungsforliving presents PET data from Summit - #lungcancer cancer screening study 👏🏼👏🏼 PET-CT has low sensitivity in patients with smaller, growing and sub-solid nodules. Can we omit PET for these patients in a screening setting? #BTOG24 #LCSM
1
8
28
RT @tnewsomdavis: Mariana Brandao: What defines operable NSCLC? EORTC consensus guidelines: 🔸 T3N1 = ✅ (resectable) 🔸T3 single station N2…
0
27
0